±èÅÂÈÆ

  • Áø·á°ú

    À̺ñÀÎÈİú

  • Àü¹®Áø·áºÐ¾ß

    ÄÚ°ñÀÌ, ¼ö¸é¹«È£ÈíÁõ, ¾Ë·¹¸£±â, ºÎºñµ¿¿°, ºñÁ߰ݸ¸°îÁõ, Èİ¢, ÄÚ¼ºÇü (¿ÀÀü 09:00 ~ 11:00)

  • ´ã´çŬ¸®´Ð

    ¾Ë·¹¸£±â ºñ¿°

  • °ü·Ã¼¾ÅÍ

    ¾Ïº´¿ø ȨÆäÀÌÁö

±èÅÂÈÆ

±èÅÂÈÆ ±³¼öÀÇ Áø·á½Ã°£Ç¥ Áø·á¿¹¾à

Áø·á°ú/¼¾ÅÍ ¿ù È­ ¼ö ¸ñ ±Ý Åä Àü¹®Áø·á°ú¸ñ
À̺ñÀÎÈİú -
¿ÀÈÄ
-
¿ÀÀü
- - ÄÚ°ñÀÌ, ¼ö¸é¹«È£ÈíÁõ, ¾Ë·¹¸£±â, ºÎºñµ¿¿°, ºñÁ߰ݸ¸°îÁõ, Èİ¢, ÄÚ¼ºÇü (¿ÀÀü 09:00 ~ 11:00)

±èÅÂÈÆ ±³¼öÀÇ »ó¼¼Á¤º¸

ÇзÂ

more
  • 1992 .03  ~  1998 .02  :  °í·Á´ëÇб³ Àǰú´ëÇÐ ÀÇÇÐ Çлç
  • 2000 .09 .01 ~  2002 .08 .31 :  °í·Á´ëÇб³ ´ëÇпø ÀÇÇÐ ¼®»ç, À̺ñÀÎÈİúÇÐ
  • 2006 .03 .01 ~  2008 .08 .31 :  °í·Á´ëÇб³ ´ëÇпø ÀÇÇÐ ¹Ú»ç, À̺ñÀÎÈİúÇÐ
  • 2012 .03 .01 ~  2014 .01 .18 :  Division of Allergy and Clinical Immunology, Division of Infectious Diseases, School of Medicine, University of California, San Diego, USA ¿¬¼ö
  • 2021 .04 .13 ~  2022 .01 .13 :  °í·Á´ëÇб³ ±â¼ú°æ¿µÀü¹®´ëÇпø, ±â¼ú°æ¿µ ÃÖ°í°æ¿µÀÚ°úÁ¤

°æ·Â

more
  • 1998 .03 .01 ~  1999 .02 .28 :  °í·Á´ëÇб³ ÀÇ·á¿ø ÀÎÅÏ
  • 1999 .03 .01 ~  2003 .03 .01 :  °í·Á´ëÇб³ ¾È¾Ïº´¿ø À̺ñÀÎÈİú Àü°øÀÇ
  • 2006 .05 .01 ~  2007 .02 .28 :  °í·Á´ëÇб³ ¾È¾Ïº´¿ø À̺ñÀÎÈİú ÀÓ»óÀüÀÓ°­»ç
  • 2007 .03 .01 ~  2009 .02 .28 :  °í·Á´ëÇб³ ¾È¾Ïº´¿ø À̺ñÀÎÈİú ÀÓ»óÁ¶±³¼ö
  • 2009 .03 .01 ~  2012 .03 .01 :  °í·Á´ëÇб³ ¾È¾Ïº´¿ø À̺ñÀÎÈİú Á¶±³¼ö
  • 2012 .03 .01 ~  2018 .02 .28 :  °í·Á´ëÇб³ ¾È¾Ïº´¿ø À̺ñÀÎÈİú ºÎ±³¼ö
  • 2016 .01 .01 ~   :  °í·Á´ëÇб³ Àǰú´ëÇÐ ÇмúÀ§¿øÈ¸ À§¿ø
  • 2016 .01 .01 ~  2018 .09 .01 :  °í·Á´ëÇб³Àǰú´ëÇÐ ¿¬±¸±³·ùºÎÇÐÀ庸/ÀÇÇÐÀü¹®´ëÇпø ¿¬±¸±³·ùºÎ¿øÀ庸
  • 2017  ~  2018 .09 .01 :  °í·Á´ëÇб³ ÀÇ·á¿ø ¾È¾Ïº´¿ø ¿¬±¸ºÎ¿øÀ庸
  • 2018 .03 .01 ~   :  °í·Á´ëÇб³ ¾È¾Ïº´¿ø À̺ñÀÎÈİú ±³¼ö
  • 2018  ~   :  KU medicine-KIST ½Å¾à ¹× Æò°¡Ç÷§Æû ¿¬±¸´ÜÀå
  • 2018  ~   :  °í·Á´ëÇб³ ¾È¾Ïº´¿ø ÀÓ»ó½ÃÇè¼¾ÅÍ ºòµ¥ÀÌÅͽÇÀå
  • 2018 .09 .18 ~  2019 .12 .31 :  °í·Á´ëÇб³ ÀÇ·á¿ø ¿¬±¸ºÎóÀå °â »êÇÐÇù·Â´Ü ºÎ´ÜÀå
  • 2019 .07 .01 ~  2019 .12 .31 :  °í·Á´ëÇб³ ÀÇ·á±â¼úÁöÁÖȸ»ç ºÎ´ëÇ¥
  • 2019 .03 .26 ~  2021 .05 .31 :  °í·Á´ëÇб³ ÀÇ·á¿ø ±¹Á¦ÀÇ·á±â±â ÀÓ»ó½ÃÇèÁö¿ø¼¾ÅÍÀå
  • 2020 .01 .20 ~   :  °í·Á´ëÇб³ ¾È¾Ïº´¿ø È«º¸½ÇÀå
  • 2020 .02 .01 ~   :  °í·Á´ëÇб³ ¾È¾Ïº´¿ø ÀÇ»ý¸í¿¬±¸¼¾ÅÍÀå
  • 2020 .03 .01 ~   :  °í·Á´ëÇб³ ¾È¾Ïº´¿ø ¿¬±¸Áö¿ø¼ÒÀå
  • 2021 .06 .01 ~  2021 .10 .31 :  °í·Á´ëÇб³ ÀÇ·á¿ø Àӻ󿬱¸Áö¿øº»ºÎÀå
  • 2021 .11 .01 ~   :  °í·Á´ëÇб³ ÀÇ·á¿ø ¿¬±¸ºÎóÀå, ¿¬±¸Àü·«º»ºÎÀå, »êÇÐÇù·ÂºÎ´ÜÀå

¼ö»ó³»¿ª

more
  • 2015  :  BRIC ¡°Çѱ¹À» ºû³½ »ç¶÷µé¡± ³í¹® ¼±Á¤ (Cyclic AMP concentrations in dendritic cells induce and regulate Th2 immunity and allergic asthma. Proc. Natl. Acad. Sci. USA, January, 2015)
  • 2018  :  ±¹Á¦ À̺ñÀÎÈİú Çмú´ëȸ (International Congress of ORL-HNS 2018) ¿ì¼ö¿¬±¸¹ßÇ¥»ó
  • 2018  :  ÀϺ» ¾Ë·¹¸£±â Çмú´ëȸ (The 67th Annual Meeting of Japanese Society of Allergology) ÇØ¿Ü ¿ì¼ö¿¬±¸¹ßÇ¥»ó
  • 2020  :  °í·Á´ëÇб³ ¼®Å¾¿¬±¸»ó
  • 2020  :  BRIC ¡°Çѱ¹À» ºû³½ »ç¶÷µé¡± ³í¹® ¼±Á¤ (A Novel Therapeutic Modality using CRISPR-Engineered Dendritic Cells to Treat Allergies. Biomaterials, April, 2021)
  • 2022  :  ´ëÇѺñ°úÇÐȸ Çмú»ó

ÇÐȸȰµ¿

more
  • 2009 .03 .01 ~  2011 .02 .28 :  ´ëÇѺñ°úÇÐȸ È«º¸À§¿ø
  • 2014 .03 .01 ~  2016 .02 .28 :  ´ëÇÑÀ̺ñÀÎÈİúÇÐȸ °£ÇàÀ§¿ø
  • 2015 .03 .01 ~  2017 .02 .28 :  ´ëÇѺñ°úÇÐȸ ºÎºñµ¿ ¿¬±¸ºÐ°ú °£»ç
  • 2016  ~  2017  :  ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ¼­¿ïÁöºÎÀ§¿ø
  • 2016 .01 .01 ~  2017 .12 .31 :  ´ëÇÑÀ̺ñÀÎÈİúÇÐȸ ±³À°¿¬±¸À§¿ø
  • 2016 .01 .01 ~  2017 .12 .31 :  ´ëÇѸ鿪ÇÐȸ ÇмúÀ§¿ø
  • 2016 .09 .01 ~  2018 .08 .31 :  Çѱ¹¿¬±¸Àç´Ü ÀǾàÇÐ´Ü Àü¹®À§¿ø (Review Board, RB)
  • 2017 .01 .01 ~  2017 .12 .31 :  ´ëÇѸ鿪ÇÐȸ À繫¿î¿µÀ§¿øÈ¸ºÎÀ§¿øÀå
  • 2017 .03 .01 ~  2019 .02 .28 :  ´ëÇѺñ°úÇÐȸ ÇмúÀ§¿ø
  • 2018 .01 .01 ~  2018 .12 .31 :  ´ëÇѸ鿪ÇÐȸ ÇмúÀ§¿ø
  • 2018 .01 .01 ~  2018 .12 .31 :  ´ëÇѸ鿪ÇÐȸ À繫¿î¿µÀ§¿øÈ¸À§¿øÀå
  • 2018 .01 .01 ~  2019 .12 .31 :  ´ëÇÑÀ̺ñÀÎÈİúÇÐȸ ÇмúÀ§¿ø
  • 2018 .01 .01 ~  2019 .12 .31 :  ´ëÇÑÀ̺ñÀÎÈİúÇÐȸ ¼ö·ÃÀ§¿ø
  • 2018 .01 .01 ~  2019 .12 .31 :  ´ëÇÑÀ̺ñÀÎÈİúÇÐȸ ±¹Á¦À§¿ø
  • 2018 .01 .01 ~  2019 .12 .31 :  ´ëÇÑÀ̺ñÀÎÈİúÇÐȸ ±³À°¿¬±¸À§¿ø
  • 2018 .01 .01 ~   :  ´ëÇÑÀ̺ñÀÎÈİúÇÐȸ ¿ªÇÐÁ¶»çÀ§¿ø
  • 2020 .01 .01 ~   :  ´ëÇÑÀ̺ñÀÎÈİúÇÐȸ ¼ö·ÃÀ§¿ø
  • 2018  ~   :  ´ëÇѼö¸éÀÇÇÐȸ ÇмúÀ§¿ø
  • 2018 .09  ~  2019 .12  :  ´ëÇÑÀ̺ñÀÎÈİúÇÐȸ ÀÌ·¯´× ÄÁÅÙÃ÷ °³¹ßÀ§¿ø
  • 2019  ~   :  ´ëÇѸ鿪ÇÐȸ ÆíÁýÀ§¿ø
  • 2019 .03 .01 ~  2021 .03 .31 :  ´ëÇѺñ°úÇÐȸ ¹ýÁ¦ÀÌ»ç
  • 2020 .07  ~  2021 .12  :  ´ëÇÑÀ̺ñÀÎÈİúÇÐȸ Àü°øÀÇ ¿¬Â÷º° ¼ö·Ã±³°ú°úÁ¤ ü°èÈ­ ¹æ¾È °³¹ßÀ§¿øÈ¸ ¼ö·Ã½ÇÅÂÁ¶»ç¼­ Á¡°Ë ¹× °³¹ß ¼ÒÀ§¿øÈ¸ À§¿øÀå
  • 2021 .04 .01 ~   :  ´ëÇѺñ°úÇÐȸ È«º¸ÀÌ»ç
  • 2022 .01 .01 ~   :  ´ëÇÑÀ̺ñÀÎÈİúÇÐȸ ¼ö·ÃÀ§¿ø

³í¹®

more
  • [SCI] (CCL2 mitigates cyclic AMP-suppressed Th2 immune response in human dendritic cells)
  • [SCI] (The Biology of Prostaglandins and Their Role as a Target for Allergic Airway Disease Therapy)
  • [SCI] (Decreased maxillary sinus volume is a potential predictor of obstructive sleep apnea)
  • [SCI] (Association between subjective olfactory dysfunction and female hormone-related factors in South Korea)
  • [SCI] (Identification of urban particulate matter-induced disruption of human respiratory mucosa integrity using whole transcriptome analysis and organ-on-a chip)
  • [SCI] (Role of Matrix Metalloproteinases 7 in the Pathogenesis of Laryngopharyngeal Reflux: Decreased E-cadherin in Acid exposed Primary Human Pharyngeal Epithelial Cells)
  • [SCI] (Incidentally-Discovered Extraosseous Cystic Nasopharyngeal Chordoma in a Papillary Thyroid Cancer Patient)
  • [SCI] (Neutrophil extracellular traps in nasal secretions of patients with stable and exacerbated chronic rhinosinusitis and their contribution to induce chemokine secretion and strengthen the epithelial barrier)
  • [SCI] (One-Pot Synthesis of Highly Monodisperse Poly(lactic‐co‐glycolic Acid) Particles with Controlled Porosity as Efficient Drug Delivery Vehicles)
  • [SCI] (Life-long endogenous estrogen exposure is associated with prevalence of allergic rhinitis in postmenopausal women)
  • [SCI] (Association of Sinonasal Factors With Chronic Laryngitis in Korean Adults)
  • [SCI] (Increased expression of interleukin 36 in chronic rhinosinusitis and its contribution to chemokine secretion and increased epithelial permeability)
  • [SCI] (Decreased expression of type I (IFN-¥â) and III interferon (IFN-¥ë) and IFN-stimulated genes in chronic rhinosinusitis with and without nasal polyps)
  • [SCI] (Effect of matrix metalloproteinase inhibitor on disrupted E-cadherin after acid exposure in the human nasal epithelium)
  • [SCI] (Role of TWIK-related potassium channel-1 in chronic rhinosinusitis)
  • [SCI] (Fundamental role of dendritic cells in inducing Th2 responses)
  • [SCI] (Asymmetric expression level of clock genes in left vs. right nasal mucosa in humans with and without allergies and in rats: Circadian characteristics and possible contribution to nasal cycle)
  • [SCI] (Decreased expression of CCL17 in the disrupted nasal polyp epithelium and its regulation by IL-4 and IL-5)
  • [SCI] (Does Snoring Time Always Reflect the Severity of Obstructive Sleep Apnea?)
  • [SCI] (Optimal dose of rocuronium bromide undergoing adenotonsillectomy under 5% sevoflurane with fentanyl)
  • [SCI] (Guidelines for the Antibiotic Use in Adults with Acute Upper Respiratory Tract Infections)
  • [SCI] (Decreased expression of E-cadherin and ZO-1 in the nasal mucosa of patients with allergic rhinitis: Altered regulation of E-cadherin by IL-4, IL-5, and TNF-alpha)
  • [SCI] (Increased expression of the aryl hydrocarbon receptor in allergic nasal mucosa, contributing to chemokine secretion in nasal epithelium)
  • [SCI] (Increased expression of hCLCA1 in chronic rhinosinusitis and its contribution to produce MUC5AC)
  • [SCI] (Cyclic AMP concentrations in dendritic cells induce and regulate Th2 immunity and allergic asthma)
  • [SCI] (Sleep quality change after upper airway surgery in obstructive sleep apnea: Electrocardiogram-based cardiopulmonary coupling analysis)
  • [SCI] (The expression of 11¥â-hydroxysteroid dehydrogenase type 1 and 2 in nasal polyp-derived epithelial cells and its possible contribution to glucocorticoid activation in nasal polyp)
  • [SCI] (The immediate effect of adenotonsillectomy on Eustachian tube function in children)
  • [SCI] (Macrolides increase the expression of 11¥â-hydroxysteroid dehydrogenase 1 in human sinonasal epithelium, contributing to glucocorticoid activation in sinonasal mucosa)
  • [SCI] (Long-term Subjective and Objective Outcomes of Adenotonsillectomy in Korean Children With Obstructive Sleep Apnea Syndrome)
  • [SCI] (Endogenous production of hydrogen sulfide in human sinus mucosa and its expression levels are altered in patients with chronic rhinosinusitis with and without nasal polyps)
  • [SCI] (Expression of 11¥â-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa)
  • [SCI] (Role of caffeic Acid on collagen production in nasal polyp-derived fibroblasts)
  • [SCI] (Expression levels of endogenous hydrogen sulfide are altered in patients with allergic rhinitis)
  • [SCI] (Chronic rhinosinusitis with polyps and without polyps is associated with increased expression of suppressors of cytokine signaling 1 and 3)
  • [SCI] (Optimal level of continuous positive airway pressure: auto-adjusting titration versus titration with a predictive equation)
  • [SCI] (Effect of isolated uvulopalatopharyngoplasty on subjective obstructive sleep apnea symptoms)
  • [SCI] (Increased expression of YKL-40 in mild and moderate/severe persistent allergic rhinitis and its possible contribution to remodeling of nasal mucosa)
  • [SCI] (Effect of upper airway surgery on heart rate variability in patients with obstructive sleep apnoea syndrome)
  • [SCI] (Effect of simvastatin on transforming growth factor beta-1-induced myofibroblast differentiation and collagen production in nasal polyp-derived fibroblasts)
  • [SCI] (Effect of [6]-gingerol on myofibroblast differentiation in transforming growth factor beta 1-induced nasal polyp-derived fibroblasts)
  • [SCI] (Expression of SOCS1 and SOCS3 is altered in the nasal mucosa of patients with mild and moderate/severe persistent allergic rhinitis)
  • [SCI] (Role of reactive oxygen species in transforming growth factor beta1-induced alpha smooth-muscle actin and collagen production in nasal polyp-derived fibroblasts)
  • [SCI] (Measuring sleep quality after adenotonsillectomy in pediatric sleep apnea)
  • [SCI] (Increased expression of intelectin-1 in nasal polyps)
  • [SCI] (The impacts of open-mouth breathing on upper airway space in obstructive sleep apnea: 3-D MDCT analysis)
  • [SCI] (Upper airway changes in severe obstructive sleep apnea: upper airway length and volumetric analyses using 3D MDCT)
  • [SCI] (Effect of successful surgical treatment on changes of position during sleep in adults with obstructive sleep apnea syndrome)
  • [SCI] (Efficacy of single-staged modified uvulopalatopharyngoplasty with nasal surgery in adults with obstructive sleep apnea syndrome)
  • [SCI] (Increased expression of a disintegrin and metalloprotease 8 in allergic rhinitis)
  • [SCI] (The expression of adiponectin receptor is altered in mild and moderate/severe persistent allergic nasal mucosa)
  • [SCI] (Effectiveness of nasal surgery alone on sleep quality, architecture, position, and sleep-disordered breathing in obstructive sleep apnea syndrome with nasal obstruction)
  • [SCI] (Remodelling of nasal mucosa in mild and severe persistent allergic rhinitis with special reference to the distribution of collagen, proteoglycans, and lymphatic vessels)
  • [SCI] (Obstructive sleep apnea syndrome: a child is not just a small adult)
  • [SCI] (The impacts of open-mouth breathing on upper airway space in obstructive sleep apnea: 3-D MDCT analysis)
  • [SCI] (Volumetric study in the development of paranasal sinuses by CT imaging in Asian: A Pilot study)
  • [SCI] (Validation study of portable device for the diagnosis of obstructive sleep apnea according to the new AASM scoring criteria: Watch-PAT 100)
  • [SCI] (Increased expression of acidic mammalian chitinase and chitotriosidase in the nasal mucosa of patients with allergic rhinitis)
  • [SCI] (Optimal continuous positive airway pressure level in korean patients with obstructive sleep apnea syndrome)
  • [SCI] (The effect of adenotonsillectomy on changes of position during sleep in pediatric obstructive sleep apnea syndrome)
  • [SCI] (Overexpression of the superoxide anion and NADPH oxidase isoforms 1 and 4 (NOX1 and NOX4) in allergic nasal mucosa)
  • [SCI] (Upregulation of elafin and cystatin C in the ethmoid sinus mucosa of patients with chronic sinusitis)
  • [SCI] (Prognostic significance of vascular endothelial growth factor-C expression and lymphatic vessel density in supraglottic squamous cell carcinoma)
  • [SCI] (Up-regulation of heparanase in the ethmoid sinus mucosa of patients with chronic sinusitis)
  • [SCI] (Expression and distribution patterns of the stem cell marker, nestin, and the stem cell renewal factor, BMI-1, in normal human nasal mucosa and nasal polyps)
  • [SCI] (Down-regulation of carbonic anhydrase isoenzymes in nasal polyps)
  • [SCI] (Overexpression of the anaphylatoxin receptors, complement anaphylatoxin 3a receptor and complement anaphylatoxin 5a receptor, in the nasal mucosa of patients with mild and severe persistent allergic rhinitis)
  • [SCI] (Increased expression of glycoprotein 340 in the ethmoid sinus mucosa of patients with chronic sinusitis)
  • [SCI] (Over-expression of neuropeptide urocortin and its receptors in human allergic nasal mucosa)
  • [SCI] (Distributional characteristics of lymphatic vessels in normal human nasal mucosa and sinus mucosa)
  • [SCI] (D2-40 immunohistochemical assessment of lymphangiogenesis in normal and edematous sinus mucosa and nasal polyp)
  • [SCI] (Effect of recombinant vascular endothelial growth factor on experimental otitis media with effusion)

Àú¼­

more
  • ÃֽŠÀÓ»óºñ°úÇÐ (Clinical Rhinology)
  • À̺ñÀÎÈİúÇÐ (Otorhinolaryngology-Head and Neck surgery)

ÃÖÁ¾¼öÁ¤ÀÏ : 2021.08.03